On Tuesday, Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) opened lower -6.65% from the last session, before settling in for the closing price of $29.63. Price fluctuations for TNXP have ranged from $6.76 to $130.00 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 73.03%. Company’s average yearly earnings per share was noted 92.65% at the time writing. With a float of $8.76 million, this company’s outstanding shares have now reached $8.77 million.
Tonix Pharmaceuticals Holding Corp (TNXP) Insider Activity
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Tonix Pharmaceuticals Holding Corp is 0.08%, while institutional ownership is 16.09%. The most recent insider transaction that took place on Aug 21 ’25, was worth 15,061. In this transaction Director of this company bought 418 shares at a rate of $36.03, taking the stock ownership to the 418 shares. Before that another transaction happened on Aug 20 ’25, when Company’s Director bought 250 for $36.00, making the entire transaction worth $9,000. This insider now owns 250 shares in total.
Tonix Pharmaceuticals Holding Corp (TNXP) Earnings and Forecasts
If we go through the results of last quarter, which was made public on 9/30/2024, the company posted -25.56 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -736) by 710.44. Wall Street market experts anticipate that the next fiscal year will bring earnings of -3.05 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 92.65% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 88.07% during the next five years compared to 73.03% growth over the previous five years of trading.
Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) Trading Performance Indicators
Check out the current performance indicators for Tonix Pharmaceuticals Holding Corp (TNXP). In the past quarter, the stock posted a quick ratio of 7.22. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 24.67.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1006.28, a number that is poised to hit -3.31 in the next quarter and is forecasted to reach -8.61 in one year’s time.
Technical Analysis of Tonix Pharmaceuticals Holding Corp (TNXP)
Looking closely at Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP), its last 5-days average volume was 0.93 million, which is a drop from its year-to-date volume of 1.39 million. As of the previous 9 days, the stock’s Stochastic %D was 2.04%.
During the past 100 days, Tonix Pharmaceuticals Holding Corp’s (TNXP) raw stochastic average was set at 23.96%, which indicates a significant increase from 1.42% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 4.67 in the past 14 days, which was higher than the 3.49 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $41.09, while its 200-day Moving Average is $27.81. However, in the short run, Tonix Pharmaceuticals Holding Corp’s stock first resistance to watch stands at $28.71. Second resistance stands at $29.76. The third major resistance level sits at $30.59. If the price goes on to break the first support level at $26.83, it is likely to go to the next support level at $26.00. Should the price break the second support level, the third support level stands at $24.95.
Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) Key Stats
There are currently 8,766K shares outstanding in the company with a market cap of 242.46 million. Presently, the company’s annual sales total 10,090 K according to its annual income of -130,040 K. Last quarter, the company’s sales amounted to 2,000 K and its income totaled -28,270 K.
